Geneos Wealth Management Inc. Celldex Therapeutics, Inc. Call Options Transaction History
Geneos Wealth Management Inc.
- $3.77 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLDX
# of Institutions
208Shares Held
68.4MCall Options Held
219KPut Options Held
238K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$145 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$138 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$111 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$93.8 Million0.0% of portfolio
-
Commodore Capital LP New York, NY3.45MShares$81.8 Million6.54% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.11B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...